COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

30,168 Articles (22,184 medRxiv, 7,984 bioRxiv)

Most recent first Previous |  Page 1493: Articles 14921-14930  | Next

Survival analysis methods for analysis of hospitalization data: Application to COVID-19 patient hospitalization experience
Rathouz, P. J., Valencia, V., Chang, P., Morton, D., Yang, H., Surer, O., Fox, S. J., Meyers, L. A., Matsui, E. C., Haynes, A. B.
10.1101/2021.04.14.21255511 — Posted: 2021-04-20
On whether therapeutic plasma exchange is an effective cure for severe/critical COVID-19 pneumonia
Cegolon, L., Einollahi, B., Imanizadeh, S., Rezapour, M., Javanbakht, M., Nikpouraghdam, M., Abolghasemi, H., Mastrangelo, G.
10.1101/2021.04.19.21255657 — Posted: 2021-04-20
Diagnostic accuracy of SARS-CoV-2 rapid antigen detection testing in symptomatic and asymptomatic children in the clinical setting
L'Huillier, A., Lacour, M., Sadiku, D., Gadiri, M. A., De Siebenthal, L., Schibler, M., Eckerle, I., Pinosch, S., Kaiser, L., Gervaix, A., Glangetas, A., Galetto-Lacour, A., Lacroix, L.
10.1101/2021.04.15.21255577 — Posted: 2021-04-20
COVID-19 transmission in a theme-park
Aruffo, E., Athar, S., Raad, A., Ali, M. A., Althubyani, M., Chow, C., Ruma, M., Liu, C., Wu, J., Asgary, A., Kong, J. D., Heffernan, J. M.
10.1101/2021.04.15.21255560 — Posted: 2021-04-20
Pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal anti-SARS-CoV-2 antibody, for COVID-19-related moderate pneumonia: a randomized, double-blind, placebo-controlled, phase IIa study
Gaborit, B., Dailly, E., Vanhove, B., Josien, R., Lacombe, K., Dubee, V., Ferre, V., Brouard, S., Ader, F., Vibet, M.-A., Le Thuaut, A., Danger, R., Omnes, A. O., Berly, L., Chiffoleau, A., Jobert, A., Duvaux, O., Raffi, F.
10.1101/2021.04.15.21255549 — Posted: 2021-04-20
Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents
Garrido, C., Hurst, J. H., Lorang, C. G., Aquino, J. N., Rodriguez, J., Pfeiffer, T. S., Singh, T., Semmes, E. C., Lugo, D. J., Rotta, A. T., Turner, N. A., Burke, T. W., McClain, M. T., Petzold, E. A., Permar, S. R., Moody, M. A., Woods, C. W., Kelly, M. S., Fouda, G. G.
10.1101/2021.04.17.21255663 — Posted: 2021-04-20
Evaluation of seven different rapid methods for nucleic acid detection of SARS-COV-2 virus
Mahmoud, S., Ibrahim, E., Ganesan, S., Thakre, B., Teddy, J., Raheja, P., Zaher, W.
10.1101/2021.04.15.21255533 — Posted: 2021-04-20
Self-collected oral, nasal and saliva samples yield sensitivity comparable to professional-collected oro-nasopharyngeal swabs in SARS-CoV-2 diagnosis
Gertler, M., Krause, E., van Loon, W., Krug, N., Kausch, F., Rohardt, C., Roessig, H., Michel, J., Nitsche, A., Mall, M. A., Nikolai, O., Hommes, F., Burock, S., Lindner, A. K., Mockenhaupt, F. P., Pison, U., Seybold, J.
10.1101/2021.04.13.21255345 — Posted: 2021-04-20
Unlocking low- and middle-income countries to detect SARS-CoV-2
Alcantara, R., Penaranda, K., Mendoza, G., Nakamoto, J. A., Martins-Luna, J., Del Valle, J., Adaui, V., Milon, P.
10.1101/2021.04.14.21255479 — Posted: 2021-04-20
The impact of COVID-19 pandemic on AMI and Stroke mortality in Lombardy: Evidence from the epicenter of the pandemic
Rossi, C., Berta, P., Curello, S., Lovaglio, P. G., Magoni, M., Metra, M., Roccaro, A. M., Verzillo, S., Vittadini, G.
10.1101/2021.04.15.21255255 — Posted: 2021-04-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).